Medicine and Dentistry
(3 Iodobenzyl)guanidine
50%
(3 Iodobenzyl)guanidine I 131
33%
Clinical Trial
16%
Combination Therapy
50%
DNA Damage
16%
Ganglioneuroblastoma
16%
In Vitro
16%
Iodine 131
50%
Noradrenalin
50%
Norepinephrine Transporter
9%
Patient
16%
Poly ADP Ribose Polymerase
50%
Poly ADP Ribose Polymerase
16%
Radiation Therapy
16%
Spontaneous Remission
16%
Therapeutic Procedure
16%
Topoisomerase Inhibitor
16%
Topotecan
50%
Toxicity
50%
Xenograft
50%
Pharmacology, Toxicology and Pharmaceutical Science
(3 Iodobenzyl)guanidine I 131
6%
Copper
50%
Cytotoxicity
9%
Disulfiram
100%
Malignant Neoplasm
50%
Neoplasm
9%
Neuroendocrine Tumor
6%
Noradrenalin
6%
Proteasome
6%
Radiosensitizing Agent
6%
Toxicity
50%